Dr Tomohiro Makino

Senior Director, Head of Cell Line Development at Bioprocess Technology Research Laboratory II at Daiichi Sankyo

Speaker

With over 25 years of experience in the pharmaceutical industry, he has dedicated his career to drug discovery and pharmaceutical research, specializing in biologics, particularly antibody-based therapeutics. He expanded his expertise through a two-year tenure as a Visiting Scholar at the University of Texas, conducting research in bioengineering and biotechnology. Currently, he serves as a manager leading a team focused on process development of antibody drug substances for Antibody-Drug Conjugates (ADCs), especially, cell line development, driving innovation in next-generation biopharmaceutical manufacturing.